Plasmid DNA Manufacturing Market (By Disease: Cancer, Infectious Diseases; By Grade: R&D Grade, GMP Grade; By Application; By Development Phase) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Plasmid DNA Manufacturing Market 

5.1. COVID-19 Landscape: Plasmid DNA Manufacturing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Plasmid DNA Manufacturing Market, By Grade 

8.1. Plasmid DNA Manufacturing Market, by Grade Scope, 2024-2033

8.1.1. R&D Grade

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. GMP Grade

8.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Plasmid DNA Manufacturing Market, By Development Phase 

9.1. Plasmid DNA Manufacturing Market, by Development Phase Scope, 2024-2033

9.1.1. Pre-clinical Therapeutics

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Clinical Therapeutics

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Marketed Therapeutics

9.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Plasmid DNA Manufacturing Market, By Application 

10.1. Plasmid DNA Manufacturing Market, by Application Scope, 2024-2033

10.1.1. DNA Vaccines

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Cell & Gene Therapy

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Immunotherapy

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Plasmid DNA Manufacturing Market, By Disease 

11.1. Plasmid DNA Manufacturing Market, by Disease Scope, 2024-2033

11.1.1. Infectious Disease

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Cancer

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Genetic Disorder

11.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Plasmid DNA Manufacturing Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.1.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.1.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.1.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.1.5.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.1.6.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.2.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.2.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.2.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.2.5.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.2.6.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.2.7.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.2.8.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.3.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.3.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.3.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.3.5.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.3.6.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.3.7.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.3.8.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.4.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.4.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.4.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.4.5.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.4.6.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.4.7.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.4.8.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.5.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.5.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.5.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.5.5.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Grade Scope (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Development Phase Scope (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Application Scope (2021-2033)

12.5.6.4. Market Revenue and Forecast, by Disease Scope (2021-2033)

Chapter 13. Company Profiles

13.1. Charles River Laboratories

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. VGXI, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Aldevron

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Kaneka Corp.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Nature Technology

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Cell and Gene Therapy Catapult

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Eurofins Genomics

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Lonza

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Luminous BioSciences, LLC

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Akron Biotech

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Frequently Asked Questions

The global plasmid DNA manufacturing market size was reached at USD 1.83 billion in 2023 and it is projected to hit around USD 12.36 billion by 2033.

The global plasmid DNA manufacturing market is growing at a compound annual growth rate (CAGR) of 21.05% from 2024 to 2033.

The North America region has accounted for the largest plasmid DNA manufacturing market share in 2023.

Report Details

  • Report Code:39735
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:February 2024
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033
  • Download Sample

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask to Expert